256 related articles for article (PubMed ID: 25677305)
1. Screening and in vitro testing of antifolate inhibitors of human cytosolic serine hydroxymethyltransferase.
Paiardini A; Fiascarelli A; Rinaldo S; Daidone F; Giardina G; Koes DR; Parroni A; Montini G; Marani M; Paone A; McDermott LA; Contestabile R; Cutruzzolà F
ChemMedChem; 2015 Mar; 10(3):490-7. PubMed ID: 25677305
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of inhibition of the human serine hydroxymethyltransferase SHMT2 by antifolate drugs.
Scaletti E; Jemth AS; Helleday T; Stenmark P
FEBS Lett; 2019 Jul; 593(14):1863-1873. PubMed ID: 31127856
[TBL] [Abstract][Full Text] [Related]
3. In silico and in vitro validation of serine hydroxymethyltransferase as a chemotherapeutic target of the antifolate drug pemetrexed.
Daidone F; Florio R; Rinaldo S; Contestabile R; di Salvo ML; Cutruzzolà F; Bossa F; Paiardini A
Eur J Med Chem; 2011 May; 46(5):1616-21. PubMed ID: 21371789
[TBL] [Abstract][Full Text] [Related]
4. Serine hydroxymethyltransferase isoforms are differentially inhibited by leucovorin: characterization and comparison of recombinant zebrafish serine hydroxymethyltransferases.
Chang WN; Tsai JN; Chen BH; Huang HS; Fu TF
Drug Metab Dispos; 2007 Nov; 35(11):2127-37. PubMed ID: 17664250
[TBL] [Abstract][Full Text] [Related]
5. Catalytic and ligand-binding characteristics of Plasmodium falciparum serine hydroxymethyltransferase.
Pang CK; Hunter JH; Gujjar R; Podutoori R; Bowman J; Mudeppa DG; Rathod PK
Mol Biochem Parasitol; 2009 Nov; 168(1):74-83. PubMed ID: 19591883
[TBL] [Abstract][Full Text] [Related]
6. Design strategy for serine hydroxymethyltransferase probes based on retro-aldol-type reaction.
Nonaka H; Nakanishi Y; Kuno S; Ota T; Mochidome K; Saito Y; Sugihara F; Takakusagi Y; Aoki I; Nagatoishi S; Tsumoto K; Sando S
Nat Commun; 2019 Feb; 10(1):876. PubMed ID: 30787298
[TBL] [Abstract][Full Text] [Related]
7. The crystal structure of human cytosolic serine hydroxymethyltransferase: a target for cancer chemotherapy.
Renwick SB; Snell K; Baumann U
Structure; 1998 Sep; 6(9):1105-16. PubMed ID: 9753690
[TBL] [Abstract][Full Text] [Related]
8. Whole-cell detection by 13C NMR of metabolic flux through the C1-tetrahydrofolate synthase/serine hydroxymethyltransferase enzyme system and effect of antifolate exposure in Saccharomyces cerevisiae.
Pasternack LB; Laude DA; Appling DR
Biochemistry; 1994 Jun; 33(23):7166-73. PubMed ID: 8003483
[TBL] [Abstract][Full Text] [Related]
9. The impact of p53 status on cellular sensitivity to antifolate drugs.
Lu X; Errington J; Curtin NJ; Lunec J; Newell DR
Clin Cancer Res; 2001 Jul; 7(7):2114-23. PubMed ID: 11448931
[TBL] [Abstract][Full Text] [Related]
10. Biochemistry and pharmacology of glycinamide ribonucleotide formyltransferase inhibitors: LY309887 and lometrexol.
Mendelsohn LG; Shih C; Schultz RM; Worzalla JF
Invest New Drugs; 1996; 14(3):287-94. PubMed ID: 8958184
[TBL] [Abstract][Full Text] [Related]
11. Effects of sulfanilamide and methotrexate on 13C fluxes through the glycine decarboxylase/serine hydroxymethyltransferase enzyme system in arabidopsis.
Prabhu V; Chatson KB; Lui H; Abrams GD; King J
Plant Physiol; 1998 Jan; 116(1):137-44. PubMed ID: 9449840
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibitory effect of a pyrazolopyran compound on human serine hydroxymethyltransferase-amino acid complexes.
Tramonti A; Paiardini A; Paone A; Bouzidi A; Giardina G; Guiducci G; Magnifico MC; Rinaldo S; McDermott L; Menendez JA; Contestabile R; Cutruzzolà F
Arch Biochem Biophys; 2018 Sep; 653():71-79. PubMed ID: 29991441
[TBL] [Abstract][Full Text] [Related]
13. Computer modelling of antifolate inhibition of folate metabolism using hybrid functional petri nets.
Assaraf YG; Ifergan I; Kadry WN; Pinter RY
J Theor Biol; 2006 Jun; 240(4):637-47. PubMed ID: 16352313
[TBL] [Abstract][Full Text] [Related]
14. Update on antifolate drugs targets.
Costi MP; Ferrari S
Curr Drug Targets; 2001 Jun; 2(2):135-66. PubMed ID: 11469716
[TBL] [Abstract][Full Text] [Related]
15. A pyrazolopyran derivative preferentially inhibits the activity of human cytosolic serine hydroxymethyltransferase and induces cell death in lung cancer cells.
Marani M; Paone A; Fiascarelli A; Macone A; Gargano M; Rinaldo S; Giardina G; Pontecorvi V; Koes D; McDermott L; Yang T; Paiardini A; Contestabile R; Cutruzzolà F
Oncotarget; 2016 Jan; 7(4):4570-83. PubMed ID: 26717037
[TBL] [Abstract][Full Text] [Related]
16. Serine hydroxymethyltransferase: role of glu75 and evidence that serine is cleaved by a retroaldol mechanism.
Szebenyi DM; Musayev FN; di Salvo ML; Safo MK; Schirch V
Biochemistry; 2004 Jun; 43(22):6865-76. PubMed ID: 15170323
[TBL] [Abstract][Full Text] [Related]
17. Folate and antifolate pharmacology.
Kamen B
Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-30-S18-39. PubMed ID: 9420019
[TBL] [Abstract][Full Text] [Related]
18. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
[TBL] [Abstract][Full Text] [Related]
19. Serine hydroxymethyltransferase as a potential target of antibacterial agents acting synergistically with one-carbon metabolism-related inhibitors.
Makino Y; Oe C; Iwama K; Suzuki S; Nishiyama A; Hasegawa K; Okuda H; Hirata K; Ueno M; Kawaji K; Sasano M; Usui E; Hosaka T; Yabuki Y; Shirouzu M; Katsumi M; Murayama K; Hayashi H; Kodama EN
Commun Biol; 2022 Jun; 5(1):619. PubMed ID: 35739195
[TBL] [Abstract][Full Text] [Related]
20. Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma.
Ducker GS; Ghergurovich JM; Mainolfi N; Suri V; Jeong SK; Hsin-Jung Li S; Friedman A; Manfredi MG; Gitai Z; Kim H; Rabinowitz JD
Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11404-11409. PubMed ID: 29073064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
